Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19

NCT04614025 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class

Stopped The decision to bring the Study to early clinical readout came in response to COVID-19's evolution as a disease, and the significant changes in the standard of care, leading to an increase in the severity of conditions of the intubated patients.

Conditions

Interventions

Sponsor

Pluristem Ltd.